9月8日 - ** 史赛克（Stryker， SYK.N）股价在午后交易中下跌9.9%，至42.65美元
** 公司高管在一次会议上指出，制造方面的挑战将持续影响今年剩余时间
** 这家医疗器械制造商此前曾指出，其外周血管业务存在生产问题，导致无法完全满足客户需求，也无法拓展新业务
** “我们原本预计这一问题将在第三季度自行解决。但目前的情况是，(的制造问题) 持续到了第三季度……我们 预计这一状况还将延续至第四季度的一小部分时间，”首席财务官普雷斯顿·韦尔斯表示
** Evercore ISI目前预计，第三季度的有机营收增长可能接近10%左右
** 史赛克表示，髋关节和膝关节置换手术量依然疲软，欧洲市场的疲软态势延续至第三季度
** 公司表示，6月份美国关节置换业务表现强劲的势头并未延续至7月和8月
** 计入盘中波动，该股今年以来累计下跌20%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.